Titan Biotech Ltd (TITANBIO) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Titan Biotech Ltd reported sales of ₹59 Cr, operating profit of ₹12 Cr (OPM 21%) and net profit of ₹11 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
TITANBIO quarterly results (₹ Cr) Metric Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 40 38 35 46 54 57 49 59 Expenses 32 33 31 38 45 46 39 47 Operating Profit 8 5 5 9 9 11 10 12 OPM 19% 13% 13% 19% 17% 19% 20% 21% Other Income 0 2 1 1 1 1 2 2 Interest 0 0 0 0 0 0 0 0 Depreciation 1 1 1 1 1 1 1 1 Profit before tax 7 5 5 8 9 11 10 13 Tax 25% 26% 25% 24% 26% 26% 36% 26% Net Profit 7 4 4 7 8 9 7 11 EPS in Rs 1.62 1.06 0.98 1.66 1.88 2.07 1.63 2.63
TITANBIO profit & loss, annual (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM Sales 124 144 164 156 206 219 Expenses 92 114 130 131 168 176 Operating Profit 31 30 34 25 39 42 OPM 25% 21% 21% 16% 19% 19% Other Income 1 2 2 4 5 6 Interest 1 1 1 1 1 1 Depreciation 2 3 3 4 5 5 Profit before tax 29 28 32 24 38 43 Tax 25% 25% 25% 25% 28% - Net Profit 22 25 25 22 30 34 EPS in Rs 5.25 6.01 6.02 5.21 7.23 8.21 Dividend Payout 6% 6% 7% 8% 7% -
TITANBIO balance sheet (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Equity Capital 8 8 8 8 8 Reserves 78 102 125 145 173 Borrowings 9 9 8 3 6 Other Liabilities 13 16 15 19 27 Total Liabilities 108 135 157 175 214 Fixed Assets 35 36 52 57 62 CWIP 4 13 3 2 2 Investments 4 15 28 33 60 Other Assets 65 70 74 83 90 Total Assets 108 135 157 175 214
TITANBIO cash flows (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity 22 21 21 20 30 Cash from Investing Activity -16 -21 -20 -10 -34 Cash from Financing Activity -4 -2 -3 -8 0 Net Cash Flow 2 -2 -2 2 -4 Free Cash Flow 8 8 12 12 21 CFO/OP 93% 97% 85% 103% 101%
TITANBIO ratios Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Debtor Days 48 53 42 44 40 Inventory Days 206 179 208 242 212 Days Payable 25 27 15 25 32 Cash Conversion Cycle 230 205 234 261 220 Working Capital Days 118 109 111 130 102 ROCE 32% 27% 25% 17% 23%